These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor. Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067 [TBL] [Abstract][Full Text] [Related]
4. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside. Badorff C; Knowlton KU Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582 [TBL] [Abstract][Full Text] [Related]
5. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication. Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy. Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091 [TBL] [Abstract][Full Text] [Related]
8. Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities. Bouin A; Gretteau PA; Wehbe M; Renois F; N'Guyen Y; Lévêque N; Vu MN; Tracy S; Chapman NM; Bruneval P; Fornes P; Semler BL; Andreoletti L Circulation; 2019 May; 139(20):2326-2338. PubMed ID: 30755025 [TBL] [Abstract][Full Text] [Related]
9. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Chapman NM; Kim KS Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes. Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926 [TBL] [Abstract][Full Text] [Related]
11. Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex. Badorff C; Lee GH; Knowlton KU Herz; 2000 May; 25(3):227-32. PubMed ID: 10904843 [TBL] [Abstract][Full Text] [Related]
12. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Tracy S; Chapman NM; Romero J; Ramsingh AI Trends Microbiol; 1996 May; 4(5):175-9. PubMed ID: 8727596 [TBL] [Abstract][Full Text] [Related]
13. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389 [TBL] [Abstract][Full Text] [Related]
14. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. Yasukawa H; Yajima T; Duplain H; Iwatate M; Kido M; Hoshijima M; Weitzman MD; Nakamura T; Woodard S; Xiong D; Yoshimura A; Chien KR; Knowlton KU J Clin Invest; 2003 Feb; 111(4):469-78. PubMed ID: 12588885 [TBL] [Abstract][Full Text] [Related]
15. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection. Yajima T Future Microbiol; 2011 May; 6(5):551-66. PubMed ID: 21585262 [TBL] [Abstract][Full Text] [Related]
16. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4. Abston ED; Coronado MJ; Bucek A; Onyimba JA; Brandt JE; Frisancho JA; Kim E; Bedja D; Sung YK; Radtke AJ; Gabrielson KL; Mitzner W; Fairweather D Am J Physiol Regul Integr Comp Physiol; 2013 Feb; 304(4):R267-77. PubMed ID: 23255589 [TBL] [Abstract][Full Text] [Related]
17. Expansion of specific alphabeta+ T-cell subsets in the myocardium of patients with myocarditis and idiopathic dilated cardiomyopathy associated with Coxsackievirus B infection. Luppi P; Rudert W; Licata A; Riboni S; Betters D; Cotrufo M; Frati G; Condorelli G; Trucco M Hum Immunol; 2003 Feb; 64(2):194-210. PubMed ID: 12559622 [TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Huber SA; Feldman AM; Sartini D Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643 [TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice. Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649 [TBL] [Abstract][Full Text] [Related]
20. Innate defense mechanism against virus infection within the cardiac myocyte requiring gp130-STAT3 signaling. Yajima T; Yasukawa H; Jeon ES; Xiong D; Dorner A; Iwatate M; Nara M; Zhou H; Summers-Torres D; Hoshijima M; Chien KR; Yoshimura A; Knowlton KU Circulation; 2006 Nov; 114(22):2364-73. PubMed ID: 17101849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]